aDepartment of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
bDepartment of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: April 27, 2022
Accepted: June 04, 2022
Published online: July 13, 2022
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3
ISSN: 1015-2008 (Print)
eISSN: 1423-0291 (Online)
For additional information: https://www.karger.com/PAT
AbstractIntroduction: Gastric cancer (GC) is a leading cause of cancer-related death worldwide. This study focused on minichromosome maintenance 4 (MCM4), a DNA helicase component that functions in DNA replication. Using spheroid colony formation, having a colony rich in cancer stem cells, this study aimed to investigate the clinicopathological importance of MCM4. Methods: We examined MCM4 expression using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) analysis in 10 and 113 GC cases, respectively. MCM4 function in GC was also investigated by RNA interference in GC cell lines. Results: In qRT-PCR and IHC analysis, high MCM4 expression was found in 60% and 83% of GC cases, respectively. MCM4-positive GC cases were significantly associated with higher T grade and tumor stage. Additionally, high MCM4 expression was significantly associated with poor prognosis and was an independent prognostic factor in multivariate analysis. MCM4 was significantly coexpressed with CD133, matrix metalloproteinase 7 (MMP7), epidermal growth factor (EGFR), and mesenchymal-epithelial transition factor (cMET). In GC cell lines, MCM4 knockdown affected cell growth and protein kinase B (Akt), extracellular signal-regulated kinase (ERK), and EGFR pathways. Conclusion: These results indicate that MCM4 expression could be a key regulator in GC progression and is pivotal in treating GC.
© 2022 S. Karger AG, Basel
References Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortalityworldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49. GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42–54. Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int J Clin Oncol. 2019;24(7):771–8. Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol. 2008;26(17):2876–82. Addeo M, Di Paola G, Verma HK, Laurino S, Russi S, Zoppoli P, et al. Gastric cancerstem cells: a glimpse on metabolicreprogramming. Front Oncol. 2021 Jun 16;11:698394. Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, et al. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int. 2012;62(2):112–9. Takaishi S, Okumura T, Tu S, Wang SSW, Shibata W, Vigneshwaran R, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009 May;27(5):1006–20. Akabane S, Oue N, Sekino Y, Asai R, Thang PQ, Taniyama D, et al. KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer. Pathol Int. 2021;71(7):441–52. Oue N, Mukai S, Imai T, Pham TTB, Oshima T, Sentani K, et al. Induction of KIFC1 expression in gastric cancer spheroids. Oncol Rep. 2016;36(1):349–55. Imai T, Oue N, Sentani K, Sakamoto N, Uraoka N, Egi H, et al. KIF11 is required for spheroid formation by oesophageal and colorectal cancer cells. Anticancer Res. 2017;37(1):47–56. Oue N, Yamamoto Y, Oshima T, Asai R, Ishikawa A, Uraoka N, et al. Overexpression of the transmembraneprotein IQGAP3 isassociated with poorsurvival of patients with gastriccancer. Pathobiology. 2018;85(3):192–200. Kearsey SE, Maiorano D, Holmes EC, Todorov IT. The role of MCM proteins in the cell cycle control of genome duplication. Bioessays. 1996 Mar;18(3):183–90. Blow JJ, Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol. 2005 Jun;6(6):476–86. Tye BK. MCM proteins in DNA replication. Annu Rev Biochem. 1999;68(1):649–86. Komamura-Kohno Y, Karasawa-Shimizu K, Saitoh T, Sato M, Hanaoka F, Tanaka S, et al. Site-specific phosphorylation of MCM4 during the cell cycle in mammalian cells. FEBS J. 2006 Mar;273(6):1224–39. Kwok HF, Zhang SD, McCrudden CM, Yuen HF, Ting KP, Wen Q, et al. Prognostic significance of minichromosome maintenance proteins in breast cancer. Am J Cancer Res. 2015;5(1):52–71. Zhou H, Jiang L, Wang G, Su L, Hou L, Xue X. Identification of MCM4 as a prognosticmarker of hepatocellularcarcinoma. Biomed Res Int. 2021;2021:1–14. Guo F, Kong WN, Feng YC, Lv J, Zhao G, Wu HL, et al. Comprehensive analysis of the expression and prognosis for MCMs in human gastric cancer. Technol Cancer Res Treat. 2020;19(789):153303382097068. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011 Jun;14(2):101–12. Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008 Jun;52(7):797–805. Fujiki Y, Ishikawa A, Akabane S, Mukai S, Maruyama R, Yamamoto Y, et al. Protocadherin B9 isassociated with humanesophagealsquamous cell carcinomaprogression. Pathobiology. 2022 Apr;1–9. Epub ahead of print. Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Takeda K, Aburatani H, et al. Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer. Lung Cancer. 2011;72(2):229–37. Choy B, LaLonde A, Que J, Wu T, Zhou Z. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions. Hum Pathol. 2016;57:126–35. Soleimani A, Dadjoo P, Avan A, Soleimanpour S, Rajabian M, Ferns G, et al. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cellbiomarker and beyond. Life Sci. 2022 Mar;293:120050. Soleyman-Jahi S, Nedjat S, Abdirad A, Hoorshad N, Heidari R, Zendehdel K. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. PLoS One. 2015;10(4):e0122316. Shi M, Liu D, Duan H, Han C, Wei B, Qian L, et al. Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Mol Cancer. 2010;9(1):269. Liu G, Jiang C, Li D, Wang R, Wang W. MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. Tumor Biol. 2014;35(10):9801–6. Guan YJ, Ma JY, Song W. Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data. Cancer Cell Int. 2019;19(1):183. Liang Z, Zhang Y, Chen Q, Hao J, Wang H, Li Y, et al. Analysis of mcm proteins’ role as a potential target of statins in patients with acute type a aortic dissection through bioinformatics. Genes. 2021;12(3):387. Article / Publication DetailsFirst-Page Preview
Received: April 27, 2022
Accepted: June 04, 2022
Published online: July 13, 2022
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3
ISSN: 1015-2008 (Print)
eISSN: 1423-0291 (Online)
For additional information: https://www.karger.com/PAT
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Comments (0)